Multidrug-Resistant Bacteria Without Borders: Role of International Trips in the Spread of Multidrug-Resistant Bacteria

Journal of Travel Medicine

Volumn 22, Issue 5, 2015, Pages 289-291

  Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; DOXYCYCLINE; ANTIINFECTIVE AGENT;

EDITORIAL; ENDEMIC DISEASE; ENTEROBACTERIACEAE; GRAM NEGATIVE INFECTION; HUMAN; INFORMATION DISSEMINATION; INTENSIVE CARE UNIT; INTESTINE FLORA; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANCE BACTERIA; NONHUMAN; RISK FACTOR; TRAVELLER DIARRHEA; BACTERIAL INFECTIONS; CROSS INFECTION; ORGANIZATION AND MANAGEMENT; PRIMARY PREVENTION; TRAVEL;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PRIMARY PREVENTION; TRAVEL;

EID: 84941082042     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12231     Document Type: Editorial

References (20)

1. Roca I, Akova M, Baquero F, et al., The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect 2015; 6: 22-29.
2. Sole M, Pitart C, Oliveira I, et al., Extended spectrum β-lactamase-producing Escherichia coli faecal carriage in Spanish travellers returning from tropical and subtropical countries. Clin Microbiol Infect 2014; 20: O636-O639.
3. Ruppé E, Armand-Lefevre L, Estellat C, et al., High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis 2015. doi: 10.1093/cid/civ333.
4. Kantele A, Lääveri T, Mero S, et al., Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis 2015; 60: 837-846.
5. Epelboin L, Robert J, Tsyrina-Kouyoumdjian E, et al., High rate of multi-drug resistant Gram-negative bacilli carriage and infection in hospitalized returning travellers: a cross-sectional cohort study. J Travel Med 2015; 22: 292-299.
6. Vento TJ, Cole DW, Mende K, et al., Multidrug-resistant Gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan. BMC Infect Dis 2013; 13: 68.
7. Davidson RJ, Davis I, Willey BM, et al., Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America. PLoS One 2008; 3: e2727.
8. Zurfluh K, Abgottspon H, Hächler H, et al., Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS One 2014; 9: e95864.
9. Angue M, Allou N, Belmonte O, et al., Risk factors for colonization with multidrug resistant bacteria among patients admitted to the intensive care unit after returning from abroad. J Travel Med 2015; 22: 300-305.
10. Allyn J, Angue M, Belmonte O, et al., Delayed diagnosis of high drug-resistant microorganisms carriage in repatriated patients: three cases in a French intensive care unit. J Travel Med 2015; 22: 215-217.
11. Kuenzli E, Jaeger VK, Frei R, et al., High colonization rates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia-a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis 2014; 14: 528.
12. Lubbert C, Straube L, Stein C, et al., Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol 2015; 305: 148-156.
13. Yaita K, Aoki K, Suzuki T, et al., Epidemiology of extended-spectrum beta-lactamase producing Escherichia coli in the stools of returning Japanese travelers, and the risk factors for colonization. PLoS One 2014; 9: e98000.
14. Peirano G, Laupland KB, Gregson DB, Pitout JD,. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med 2011; 18: 299-303.
15. Weisenberg SA, Mediavilla JR, Chen L, et al., Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City. PLoS One 2012; 7: e45141.
16. Tangden T, Cars O, Melhus A, Lowdin E,. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-3568.
17. Ostholm-Balkhed A, Tarnberg M, Nilsson M, et al., Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother 2013; 68: 2144-2153.
18. Paltansing S, Vlot JA, Kraakman ME, et al., Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis 2013; 19: 1206-1213.
19. von Wintersdorff CJ, Penders J, Stobberingh EE, et al., High rates of antimicrobial drug resistance gene acquisition after international travel, The Netherlands. Emerg Infect Dis 2014; 20: 649-657.
20. Fournier S, Lepainteur M, Kassis-Chikhani N, et al., Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution. J Travel Med 2012; 19: 320-323.